Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

2020127 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 159, Issue 5, pp. 1985-1987.e4

Field-Weighted Citation Impact: 12.22